Latest Xolair news
Omalizumab, Multiallergen OIT Both Viable for Multifood Allergy Treatment
posted August 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
AAAAI: Omalizumab as Effective as Multifood Oral Immunotherapy for Individuals With Food Allergy
posted March 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Recommendations Developed for Optimizing Biologics in Adults With Severe Asthma
posted January 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Omalizumab Protects Against Early, Late Allergic Responses
posted June 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
For patients with a significant response to allergen challenge, omalizumab induces protective effects against early and late allergic reactions, according to a study published online June 5 in Allergy.
Editor's Recommendations
Exacerbation Risk Profiles Vary With House Dust Mite Sensitization in Pediatric Asthma 
Eosinophilic Esophagitis Prevalence May Be Higher Than Thought in Pediatric Patients With Asthma 
Real-Time Pollen Data Perceived as Valuable Among Some With Seasonal Allergies 
C-Section, Maternal History of Allergic Diseases Linked to Allergic Rhinitis in Offspring 
Glyphosate Exposure During Pregnancy Linked to Preterm Birth 
Family-Based Behavioral Treatment Improves Child Weight Outcomes 
Phelan-McDermid Syndrome More Prevalent Than Previously Estimated 
Consumption of Ultraprocessed Foods in Early Childhood Linked to Brain Development Monthly Specialist Briefings
Stay Connected
